Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b

Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Bioanalytical Challenges of Biosimilars
Challenges and Solutions Seminar Series Register now: http://www.somrubioscience.com/page/somru-seminar Ready to..
Read More ...Somru BioScience gets $4M
‘This is really about strengthening the local ecosystem’ Source: CBC..
Read More ...Biomarker Assays
Biomarker Assays Solutions Qualified biomarker method list Custom reagent generation..
Read More ...Cell and Gene Therapy
Cell & Gene Therapy Solutions Pharmacokinetics (PK) & Biodistribution Branched..
Read More ...